NICE recommends first licensed treatment for vitiligo Guidance says that ruxolitinib cream can be used as treatment for vitiligo if other first-line treatments — such as including topical corticosteroids and light therapy — do not work.…
Health news round-up: GLP-1s for psoriasis, promise for people with cancer and pharmacogenomics A weekly summary of important developments in pharmacy and health news that you may have missed.…
NICE widens access to SGLT-2 inhibitors and GLP-1s in updated type 2 diabetes guidance The National Institute for Health and Care Excellence said the changes could prevent up to 17,000 deaths in the UK over three years.…
Over-the-counter medicines are being purchased by children as young as 13 years, reveals survey Overall, more than half of the survey respondents had used over-the-counter medicines in a six-month period.…
Two-fifths of children have seen weight-loss drugs online despite ban The results of a survey conducted by the Children’s Commissioner revealed that girls were more likely than boys to see adverts for weight-loss injections online.…
Health news round-up: medicines in pregnancy, GLP-1s and eating disorders, and new cancer treatments A weekly summary of important developments in pharmacy and health news that you may have missed.…
The dark side of the ‘miracle jab’: why eating disorder safety cannot be an afterthought As the use of glucagon-like peptide-1 receptor agonists increases, so must our awareness of patients who have an eating disorder or who are at risk of developing one.…
Health news round-up: travel warnings, AMR in children, and the latest on medicine supply A weekly summary of important developments in pharmacy and health news that you may have missed.…
Everything you need to know about GLP-1s for weight loss From semaglutide to tirzepatide, this article collates the latest information on pharmacological weight-loss treatments, including evidence and best practice for their use.…
Health news round-up: NICE approvals, surveillance data and GLP-1 warnings A weekly summary of important developments in pharmacy and health news that you may have missed.…
